Press Release: Open PHACTS Foundation announces first three members: GSK, Janssen and Roche

(PDFCambridge, UK – The not-for-profit Open PHACTS Foundation announced its first three members today – GlaxoSmithKline, Janssen and Roche – who will steer the future of the successor organisation to the Innovative Medicines Initiative (IMI)- funded Open PHACTS project.

The commitment by these global pharmaceutical industry members signifies a major step in ensuring the sustainability of infrastructure developed during the Open PHACTS project.

[…]

Publication: Druggable and biopharmable genome annotation pipeline development

The identification of proteins which could be potential targets for new pharmaceutical products is invaluable for the continued improvement people’s quality of life and expansion of available treatment options. In order to aid the discovery of new drug targets, predictions of every human gene likely to be exploitable by compounds and biotechnology were generated using Read more about Publication: Druggable and biopharmable genome annotation pipeline development[…]